Home / Almoosa Health Co. / 2024 Annual Results

Almoosa Health Co. 2024 Annual Results

Revenue

SAR 1.20B

Net Profit

SAR 94M

EPS

SAR 2.70

Operating Cash Flow

SAR 184M

Almoosa Health Co. (4018) reported full year 2024 revenue of SAR 1.20B, up 22.8% from SAR 979M in 2023. Net profit came in at SAR 94M, down 3.8% year on year. Earnings per share were SAR 2.70. The company generated SAR 184M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.95 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.95.

Key Financial Metrics

Metric	2024	2023
Revenue	SAR 1.20B	SAR 979M
Net Profit	SAR 94M	SAR 98M
Net Margin	7.8%	10.0%
ROE	13.2%	15.0%
EPS	SAR 2.70	SAR 2.80
Total Assets	SAR 2.55B	SAR 2.30B
Total Equity	SAR 718M	SAR 656M
Total Liabilities	SAR 1.84B	SAR 1.65B
Operating Cash Flow	SAR 184M	SAR 40M

Year on Year Comparison

Revenue increased by 22.8% compared to 2023. Net profit decreased by 3.8%. Revenue grew but profit declined — suggesting margin pressure.

View full company profile →

View all years:

2025 2024 2023

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2025-05-05.